BIOHAVEN PHARMACEUTICALS INC has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan BIOHAVEN PHARMACEUTICALS INC 401K PLAN
| Measure | Date | Value |
|---|
| 2023 : BIOHAVEN PHARMACEUTICALS INC 401K PLAN 2023 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2023-12-31 | $0 |
| Total transfer of assets to this plan | 2023-12-31 | $0 |
| Total transfer of assets from this plan | 2023-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $0 |
| Total income from all sources (including contributions) | 2023-12-31 | $19,385,028 |
| Total loss/gain on sale of assets | 2023-12-31 | $0 |
| Total of all expenses incurred | 2023-12-31 | $41,552,883 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-12-31 | $41,203,081 |
| Expenses. Certain deemed distributions of participant loans | 2023-12-31 | $120,071 |
| Value of total corrective distributions | 2023-12-31 | $18,649 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-12-31 | $9,451,531 |
| Value of total assets at end of year | 2023-12-31 | $52,502,307 |
| Value of total assets at beginning of year | 2023-12-31 | $74,670,162 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-12-31 | $211,082 |
| Total interest from all sources | 2023-12-31 | $12,330 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-12-31 | $2,074,957 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2023-12-31 | $2,074,957 |
| Was this plan covered by a fidelity bond | 2023-12-31 | Yes |
| Value of fidelity bond cover | 2023-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2023-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2023-12-31 | No |
| Contributions received from participants | 2023-12-31 | $4,676,885 |
| Participant contributions at end of year | 2023-12-31 | $44,307 |
| Participant contributions at beginning of year | 2023-12-31 | $433,752 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2023-12-31 | $2,002,139 |
| Other income not declared elsewhere | 2023-12-31 | $378,025 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-12-31 | No |
| Value of net income/loss | 2023-12-31 | $-22,167,855 |
| Value of net assets at end of year (total assets less liabilities) | 2023-12-31 | $52,502,307 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-12-31 | $74,670,162 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2023-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2023-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2023-12-31 | No |
| Investment advisory and management fees | 2023-12-31 | $90,353 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2023-12-31 | $45,082,612 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2023-12-31 | $63,485,683 |
| Interest on participant loans | 2023-12-31 | $12,330 |
| Value of interest in common/collective trusts at end of year | 2023-12-31 | $7,375,388 |
| Value of interest in common/collective trusts at beginning of year | 2023-12-31 | $10,750,727 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2023-12-31 | $6,220,155 |
| Net investment gain or loss from common/collective trusts | 2023-12-31 | $1,248,030 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2023-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2023-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2023-12-31 | No |
| Contributions received in cash from employer | 2023-12-31 | $2,772,507 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2023-12-31 | $41,203,081 |
| Did the plan have assets held for investment | 2023-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2023-12-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2023-12-31 | Unqualified |
| Accountancy firm name | 2023-12-31 | ERNST & YOUNG LLP |
| Accountancy firm EIN | 2023-12-31 | 346565596 |
| Total unrealized appreciation/depreciation of assets | 2023-01-01 | $0 |
| Total transfer of assets to this plan | 2023-01-01 | $0 |
| Total transfer of assets from this plan | 2023-01-01 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-01-01 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-01-01 | $0 |
| Total income from all sources (including contributions) | 2023-01-01 | $19,385,028 |
| Total loss/gain on sale of assets | 2023-01-01 | $0 |
| Total of all expenses incurred | 2023-01-01 | $41,552,883 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-01-01 | $41,203,081 |
| Expenses. Certain deemed distributions of participant loans | 2023-01-01 | $120,071 |
| Value of total corrective distributions | 2023-01-01 | $18,649 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-01-01 | $9,451,531 |
| Value of total assets at end of year | 2023-01-01 | $52,502,307 |
| Value of total assets at beginning of year | 2023-01-01 | $74,670,162 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-01-01 | $211,082 |
| Total interest from all sources | 2023-01-01 | $12,330 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-01-01 | $2,074,957 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-01-01 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2023-01-01 | $2,074,957 |
| Was this plan covered by a fidelity bond | 2023-01-01 | Yes |
| Value of fidelity bond cover | 2023-01-01 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2023-01-01 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2023-01-01 | No |
| Contributions received from participants | 2023-01-01 | $4,676,885 |
| Participant contributions at end of year | 2023-01-01 | $44,307 |
| Participant contributions at beginning of year | 2023-01-01 | $433,752 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2023-01-01 | $2,002,139 |
| Other income not declared elsewhere | 2023-01-01 | $378,025 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-01-01 | No |
| Value of net income/loss | 2023-01-01 | $-22,167,855 |
| Value of net assets at end of year (total assets less liabilities) | 2023-01-01 | $52,502,307 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-01-01 | $74,670,162 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2023-01-01 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2023-01-01 | No |
| Were any leases to which the plan was party in default or uncollectible | 2023-01-01 | No |
| Investment advisory and management fees | 2023-01-01 | $90,353 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2023-01-01 | $45,082,612 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2023-01-01 | $63,485,683 |
| Interest on participant loans | 2023-01-01 | $12,330 |
| Value of interest in common/collective trusts at end of year | 2023-01-01 | $7,375,388 |
| Value of interest in common/collective trusts at beginning of year | 2023-01-01 | $10,750,727 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2023-01-01 | $6,220,155 |
| Net investment gain or loss from common/collective trusts | 2023-01-01 | $1,248,030 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2023-01-01 | No |
| Was there a failure to transmit to the plan any participant contributions | 2023-01-01 | No |
| Has the plan failed to provide any benefit when due under the plan | 2023-01-01 | No |
| Contributions received in cash from employer | 2023-01-01 | $2,772,507 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2023-01-01 | $41,203,081 |
| Did the plan have assets held for investment | 2023-01-01 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-01-01 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2023-01-01 | No |
| Opinion of an independent qualified public accountant for this plan | 2023-01-01 | 1 |
| Accountancy firm name | 2023-01-01 | ERNST & YOUNG LLP |
| Accountancy firm EIN | 2023-01-01 | 346565596 |
| 2022 : BIOHAVEN PHARMACEUTICALS INC 401K PLAN 2022 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2022-12-31 | $0 |
| Total transfer of assets to this plan | 2022-12-31 | $0 |
| Total transfer of assets from this plan | 2022-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
| Total income from all sources (including contributions) | 2022-12-31 | $19,634,574 |
| Total loss/gain on sale of assets | 2022-12-31 | $0 |
| Total of all expenses incurred | 2022-12-31 | $3,085,382 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $2,890,394 |
| Expenses. Certain deemed distributions of participant loans | 2022-12-31 | $16,385 |
| Value of total corrective distributions | 2022-12-31 | $13,709 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $31,622,125 |
| Value of total assets at end of year | 2022-12-31 | $74,670,162 |
| Value of total assets at beginning of year | 2022-12-31 | $58,120,970 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $164,894 |
| Total interest from all sources | 2022-12-31 | $26,963 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $4,703,311 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-31 | $4,703,311 |
| Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
| Value of fidelity bond cover | 2022-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2022-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
| Contributions received from participants | 2022-12-31 | $17,697,167 |
| Participant contributions at end of year | 2022-12-31 | $433,752 |
| Participant contributions at beginning of year | 2022-12-31 | $486,167 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2022-12-31 | $5,834,796 |
| Other income not declared elsewhere | 2022-12-31 | $104,767 |
| Administrative expenses (other) incurred | 2022-12-31 | $164,894 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
| Value of net income/loss | 2022-12-31 | $16,549,192 |
| Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $74,670,162 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $58,120,970 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $63,485,683 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $49,693,656 |
| Interest on participant loans | 2022-12-31 | $26,963 |
| Value of interest in common/collective trusts at end of year | 2022-12-31 | $10,750,727 |
| Value of interest in common/collective trusts at beginning of year | 2022-12-31 | $7,941,147 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $-15,536,212 |
| Net investment gain or loss from common/collective trusts | 2022-12-31 | $-1,286,380 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
| Contributions received in cash from employer | 2022-12-31 | $8,090,162 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $2,890,394 |
| Did the plan have assets held for investment | 2022-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2022-12-31 | Unqualified |
| Accountancy firm name | 2022-12-31 | ERNST & YOUNG LLP |
| Accountancy firm EIN | 2022-12-31 | 346565596 |
| Total unrealized appreciation/depreciation of assets | 2022-01-01 | $0 |
| Total transfer of assets to this plan | 2022-01-01 | $0 |
| Total transfer of assets from this plan | 2022-01-01 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-01-01 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-01-01 | $0 |
| Total income from all sources (including contributions) | 2022-01-01 | $19,634,574 |
| Total loss/gain on sale of assets | 2022-01-01 | $0 |
| Total of all expenses incurred | 2022-01-01 | $3,085,382 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-01-01 | $2,890,394 |
| Expenses. Certain deemed distributions of participant loans | 2022-01-01 | $16,385 |
| Value of total corrective distributions | 2022-01-01 | $13,709 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-01-01 | $31,622,125 |
| Value of total assets at end of year | 2022-01-01 | $74,670,162 |
| Value of total assets at beginning of year | 2022-01-01 | $58,120,970 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-01-01 | $164,894 |
| Total interest from all sources | 2022-01-01 | $26,963 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-01-01 | $4,703,311 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-01-01 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2022-01-01 | $4,703,311 |
| Was this plan covered by a fidelity bond | 2022-01-01 | Yes |
| Value of fidelity bond cover | 2022-01-01 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2022-01-01 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2022-01-01 | No |
| Contributions received from participants | 2022-01-01 | $17,697,167 |
| Participant contributions at end of year | 2022-01-01 | $433,752 |
| Participant contributions at beginning of year | 2022-01-01 | $486,167 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2022-01-01 | $5,834,796 |
| Other income not declared elsewhere | 2022-01-01 | $104,767 |
| Administrative expenses (other) incurred | 2022-01-01 | $164,894 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-01-01 | No |
| Value of net income/loss | 2022-01-01 | $16,549,192 |
| Value of net assets at end of year (total assets less liabilities) | 2022-01-01 | $74,670,162 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-01-01 | $58,120,970 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-01-01 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2022-01-01 | No |
| Were any leases to which the plan was party in default or uncollectible | 2022-01-01 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-01-01 | $63,485,683 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-01-01 | $49,693,656 |
| Interest on participant loans | 2022-01-01 | $26,963 |
| Value of interest in common/collective trusts at end of year | 2022-01-01 | $10,750,727 |
| Value of interest in common/collective trusts at beginning of year | 2022-01-01 | $7,941,147 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-01-01 | $-15,536,212 |
| Net investment gain or loss from common/collective trusts | 2022-01-01 | $-1,286,380 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-01-01 | No |
| Was there a failure to transmit to the plan any participant contributions | 2022-01-01 | No |
| Has the plan failed to provide any benefit when due under the plan | 2022-01-01 | No |
| Contributions received in cash from employer | 2022-01-01 | $8,090,162 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-01-01 | $2,890,394 |
| Did the plan have assets held for investment | 2022-01-01 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-01-01 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-01-01 | No |
| Opinion of an independent qualified public accountant for this plan | 2022-01-01 | 1 |
| Accountancy firm name | 2022-01-01 | ERNST & YOUNG LLP |
| Accountancy firm EIN | 2022-01-01 | 346565596 |
| 2021 : BIOHAVEN PHARMACEUTICALS INC 401K PLAN 2021 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2021-12-31 | $0 |
| Total transfer of assets to this plan | 2021-12-31 | $0 |
| Total transfer of assets from this plan | 2021-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
| Total income from all sources (including contributions) | 2021-12-31 | $27,661,557 |
| Total loss/gain on sale of assets | 2021-12-31 | $0 |
| Total of all expenses incurred | 2021-12-31 | $2,078,403 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $2,039,382 |
| Value of total corrective distributions | 2021-12-31 | $1,757 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $21,372,925 |
| Value of total assets at end of year | 2021-12-31 | $58,120,970 |
| Value of total assets at beginning of year | 2021-12-31 | $32,537,816 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $37,264 |
| Total interest from all sources | 2021-12-31 | $21,650 |
| Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $3,896,143 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $3,896,143 |
| Was this plan covered by a fidelity bond | 2021-12-31 | Yes |
| Value of fidelity bond cover | 2021-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2021-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
| Contributions received from participants | 2021-12-31 | $12,976,209 |
| Participant contributions at end of year | 2021-12-31 | $486,167 |
| Participant contributions at beginning of year | 2021-12-31 | $351,029 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2021-12-31 | $2,737,160 |
| Administrative expenses (other) incurred | 2021-12-31 | $37,264 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
| Value of net income/loss | 2021-12-31 | $25,583,154 |
| Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $58,120,970 |
| Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $32,537,816 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $49,693,656 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $28,185,558 |
| Interest on participant loans | 2021-12-31 | $21,650 |
| Value of interest in common/collective trusts at end of year | 2021-12-31 | $7,941,147 |
| Value of interest in common/collective trusts at beginning of year | 2021-12-31 | $4,001,229 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $1,464,779 |
| Net investment gain or loss from common/collective trusts | 2021-12-31 | $906,060 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
| Contributions received in cash from employer | 2021-12-31 | $5,659,556 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $2,039,382 |
| Did the plan have assets held for investment | 2021-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Unqualified |
| Accountancy firm name | 2021-12-31 | ERNST & YOUNG LLP |
| Accountancy firm EIN | 2021-12-31 | 346565596 |
| 2020 : BIOHAVEN PHARMACEUTICALS INC 401K PLAN 2020 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2020-12-31 | $0 |
| Total transfer of assets to this plan | 2020-12-31 | $0 |
| Total transfer of assets from this plan | 2020-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
| Total income from all sources (including contributions) | 2020-12-31 | $24,273,049 |
| Total loss/gain on sale of assets | 2020-12-31 | $0 |
| Total of all expenses incurred | 2020-12-31 | $1,185,519 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $1,163,523 |
| Value of total corrective distributions | 2020-12-31 | $17,907 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $19,437,958 |
| Value of total assets at end of year | 2020-12-31 | $32,537,816 |
| Value of total assets at beginning of year | 2020-12-31 | $9,450,286 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $4,089 |
| Total interest from all sources | 2020-12-31 | $10,125 |
| Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $1,310,832 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $1,310,832 |
| Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
| Value of fidelity bond cover | 2020-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2020-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
| Contributions received from participants | 2020-12-31 | $10,517,897 |
| Participant contributions at end of year | 2020-12-31 | $351,029 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2020-12-31 | $4,161,167 |
| Administrative expenses (other) incurred | 2020-12-31 | $4,089 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
| Value of net income/loss | 2020-12-31 | $23,087,530 |
| Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $32,537,816 |
| Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $9,450,286 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $28,185,558 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $8,448,460 |
| Interest on participant loans | 2020-12-31 | $10,125 |
| Value of interest in common/collective trusts at end of year | 2020-12-31 | $4,001,229 |
| Value of interest in common/collective trusts at beginning of year | 2020-12-31 | $1,001,826 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $3,043,288 |
| Net investment gain or loss from common/collective trusts | 2020-12-31 | $470,846 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
| Contributions received in cash from employer | 2020-12-31 | $4,758,894 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $1,163,523 |
| Did the plan have assets held for investment | 2020-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Disclaimer |
| Accountancy firm name | 2020-12-31 | ERNST & YOUNG LLP |
| Accountancy firm EIN | 2020-12-31 | 346565596 |
